Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Balestro, E. Rossi, A. Floriani, C. Rinaldo, F. Lunardi, M. Loy, F. Rea, M. Cosio, M. Saetta, F. Calabrese (Padova, Italy). Natural history of idiopathic pulmonary fibrosis: Are slowly progressive and rapidly progressive really steady conditions?. Eur Respir J 2012; 40: Suppl. 56, 3638

Member's Comments

No comment yet.

Related content which might interest you: A prothrombotic state is associated with increased mortality in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003 The natural history of progressive fibrosing interstitial lung diseases Source: Eur Respir J, 55 (6) 2000085; 10.1183/13993003.00085-2020 Year: 2020 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Severe idiopathic pulmonary fibrosis: what can be done? Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017 Year: 2017 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 The changing treatment landscape in idiopathic pulmonary fibrosis Source: Eur Respir Rev 2015; 24: 65-68 Year: 2015 Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016 Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm Source: Eur Respir J 2015; 46: 512-520 Year: 2015 Effect of 24-month Pirfenidone treatment on functional decline in Idiopathic Pulmonary Fibrosis (IPF) patients with rapid and slow disease progression Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Slow versus rapid progressors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Idiopathic pulmonary fibrosis: time for greater expectations? Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018 Year: 2018 Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Source: Eur Respir J 2007; 30: 835-839 Year: 2007 Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis Source: Eur Respir J, 56 (3) 1902058; 10.1183/13993003.02058-2019 Year: 2020 Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009 The therapy of idiopathic pulmonary fibrosis: what is next? Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019 Year: 2019 Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis Source: Eur Respir J 2013; 42: 916-923 Year: 2013 The ratio AGE/RAGE is increased in idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015